These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 10812443

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness estimates for antenatal HIV testing in the Netherlands.
    Rozenbaum MH, Verweel G, Folkerts DK, Dronkers F, van den Hoek JA, Hartwig NG, de Groot R, Postma MJ.
    Int J STD AIDS; 2008 Oct; 19(10):668-75. PubMed ID: 18824618
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.
    Gorsky RD, Farnham PG, Straus WL, Caldwell B, Holtgrave DR, Simonds RJ, Rogers MF, Guinan ME.
    Public Health Rep; 1996 Oct; 111(4):335-41. PubMed ID: 8711101
    [Abstract] [Full Text] [Related]

  • 6. [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Postma MJ, Bakker A, Welte R, van Bergen JE, van den Hoek JA, de Jong-van den Berg LT, Jager JC.
    Ned Tijdschr Geneeskd; 2000 Dec 02; 144(49):2350-4. PubMed ID: 11129971
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis.
    Plunkett BA, Grobman WA.
    Am J Obstet Gynecol; 2005 Apr 02; 192(4):1153-61. PubMed ID: 15846195
    [Abstract] [Full Text] [Related]

  • 14. Voluntary screening program for HIV in pregnancy. Cost effectiveness.
    Rivera-Alsina ME, Rivera CC, Rollene N, Kirby RS, Ayres A, McNamara M.
    J Reprod Med; 2001 Mar 02; 46(3):243-8. PubMed ID: 11304866
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease.
    Akker-van Marle ME, Rijnders ME, Dommelen P, Fekkes M, Wouwe JP, Amelink-Verburg MP, Verkerk PH.
    BJOG; 2005 Jun 02; 112(6):820-6. PubMed ID: 15924544
    [Abstract] [Full Text] [Related]

  • 16. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening.
    Mauskopf JA, Paul JE, Wichman DS, White AD, Tilson HH.
    JAMA; 1996 Jul 10; 276(2):132-8. PubMed ID: 8656505
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.